D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism

Neurobiology of Disease

Volumn 35, Issue 3, 2009, Pages 376-384

  Ballion, Bérangère ^a,b   Frenois, Francois ^a,b   Zold, Camila L ^c   Chetrit, Jonathan ^a,b   Murer, M Gustavo ^c   Gonon, Francois ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UMR 5287   (France)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Dopamine; Electrophysiology; GABA interneuron; Levodopa; Parkinson's disease; Quinpirole; Striatonigral; Striatopallidal; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; APOMORPHINE; BENSERAZIDE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; LEVODOPA; OXIDOPAMINE; PROTEIN C FOS; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DISEASE MODEL; GLOBUS PALLIDUS; MALE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; RECEPTOR UPREGULATION; SPIKE WAVE; STRIATE CORTEX; TREATMENT RESPONSE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACTION POTENTIALS; ANIMALS; ANTIPARKINSON AGENTS; APOMORPHINE; BENSERAZIDE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DOPAMINE AGONISTS; LEVODOPA; MALE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 68149161321     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.05.019     Document Type: Article

References (49)

1. Albin R.L., et al. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
2. Ballion B., et al. Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism. Eur. J. Neurosci. 27 (2008) 2313-2321
3. Bezard E., et al. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat. Rev. Neurosci. 2 (2001) 577-588
4. Boraud T., et al. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain 124 (2001) 546-557
5. Brotchie J.M., et al. Levodopa-induced dyskinesia in Parkinson's disease. J. Neural. Transm. 112 (2005) 359-391
6. Carta A.R., et al. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Eur. J. Neurosci. 21 (2005) 1196-1204
7. Cenci M.A. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci. 30 (2007) 236-243
8. Day M., et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat. Neurosci. 9 (2006) 251-259
9. Delgado A., et al. Inhibitory control of the GABAergic transmission in the rat neostriatum by D(2) dopamine receptors. Neuroscience 95 (2000) 1043-1048
10. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13 (1990) 281-285
11. Deng Y.P., et al. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J. Chem. Neuroanat. 32 (2006) 101-116
12. Fletcher G.H., and Starr M.S. Differential effects of pallidal lesions on the behavioural responses to SKF 38393, LY 171555 and apomorphine in the rat. Neuroscience 28 (1989) 171-180
13. Frenois F., et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 32 (2007) 516-531
14. Gantois I., et al. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4182-4187
15. Gerfen C.R. Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci. 23 (2000) S64-70
16. In: Gerfen C.R., and Wilson C.J. (Eds). The Basal Ganglia (1996), Elsevier, Amsterdam
17. Gerfen C.R., et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
18. Gerfen C.R., et al. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15 (1995) 8167-8176
19. Gerfen C.R., et al. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J. Neurosci. 22 (2002) 5042-5054
20. Gonon F., et al. Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter. Prog. Brain Res. 25 (2000) 291-302
21. Goto Y., et al. The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 53 (2007) 583-587
22. Hauser R.A., et al. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa. Mov. Disord. 22 (2007) 2409-2417
23. Hersch S.M., et al. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J. Neurosci. 15 (1995) 5222-5237
24. Horstink M., et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur. J. Neurol. 13 (2006) 1170-1185
25. Horstink M., et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur. J. Neurol. 13 (2006) 1186-1202
26. Jaeger D., et al. Surround inhibition among projection neurons is weak or nonexistent in the rat neostriatum. J. Neurophysiol. 72 (1994) 2555-2558
27. Kita H. Physiology of two disynaptic pathways from the sensori-motor cortex to the basal ganglia output nuclei. In: Percheron G., et al. (Ed). The Basal Ganglia IV. (1994), Plenum, New York
28. LaHoste G.J., and Marshall J.F. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists. Behav. Brain Res. 38 (1990) 233-242
29. Le Moine C., and Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355 (1995) 418-426
30. Leblois A., et al. Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia. J. Neurosci. 26 (2006) 3567-3583
31. Lindgren H.S., et al. The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration. Behav. Brain Res. 177 (2007) 150-159
32. Lundblad M., et al. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur. J. Neurosci. 15 (2002) 120-132
33. Mallet N., et al. Feedforward inhibition of projection neurons by fast spiking GABA interneurons in the rat striatum in vivo. J. Neurosci. 25 (2005) 3857-3869
34. Mallet N., et al. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of Parkinsonian rats. J. Neurosci. 26 (2006) 3875-3884
35. Maurice N., et al. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits. J. Neurosci. 19 (1999) 4674-4681
36. Meissner W., et al. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol. Dis. 22 (2006) 586-598
37. Paul M.L., et al. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Neuroscience 66 (1995) 347-359
38. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, London
39. Rascol O., et al. Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch. Neurol. 58 (2001) 249-254
40. Richfield E.K., et al. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience 30 (1989) 767-777
41. Robertson H.A., et al. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res. 503 (1989) 346-349
42. Robertson G.S., et al. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res. 523 (1990) 288-290
43. Ruskin D.N., et al. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei. Neuroscience 91 (1999) 935-946
44. Ryan L.J., et al. Substantia nigra stimulation evoked antidromic responses in rat neostriatum. Exp. Brain Res. 63 (1986) 449-460
45. Ryan L.J., et al. Antidromically identified striatonigral projection neurons in the chronically implanted behaving rat: relations of cell firing to amphetamine-induced behaviors. Behav. Neurosci. 103 (1989) 3-14
46. Schapira A.H. Treatment options in the modern management of Parkinson disease. Arch. Neurol. 64 (2007) 1083-1088
47. Sgambato V., et al. Effect of a functional impairment of corticostriatal transmission on cortically evoked expression of c-Fos and zif 268 in the rat basal ganglia. Neuroscience 93 (1999) 1313-1321
48. Tecuapetla F., et al. Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10258-10263
49. Zold C., et al. Nigrostriatal lesion induces D2 modulated phase locked activity in the basal ganglia of rats. Eur. J. Neurosci. 25 (2007) 2131-2144